Mahima Datla Usa India county Baylor city Hyderabad hospital covid-19 vaccine medicines Mahima Datla Usa India county Baylor city Hyderabad

Biological E starts human trials of Baylor College’s covid-19 vaccine

Reading now: 736
www.livemint.com

covid-19 subunit vaccine candidate, developed by US-based Baylor College of Medicine, in India following approval from the Drugs Controller General of India (DGCI).

The vaccine candidate is fourth to start human trials in India.The Hyderabad-based vaccine manufacturer has partnered with Baylor College and US-based Dynavax Technologies Corporation for development of the vaccine.“We are very happy indeed to transition our potential vaccine candidate to clinical trials and offer one more potential option for the prophylaxis of COVID-19," Biological E managing director Mahima Datla said in a statement.Biological E expects the results of the phase I and II clinical trials to be available by February.Biological E’s vaccine candidate includes an.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA